VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Technical Scanner
RSI, Moving averages & volume momentum signals
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
Minervini — VCPContraction bases in Stage 2 uptrends
Minervini — Trend TemplateFull 8-rule Stage 2 screen
O'Neil — Cup with HandleBase breakouts with RS leadership
O'Neil — CANSLIM LeadersGrowth leaders with RS ≥ 85
Qullamaggie — High Tight FlagsPower plays after a large advance
Qullamaggie — Momentum Leaders1/3/6-month strength leaders
Livermore — Pivotal PointsMulti-touch resistance breakouts
View All Playbooks...
Breakouts
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
Breakouts
WatchlistPricing
Ctrl K
Pricing
MCK
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsCompareWatchlist
MCKMcKesson Corporation
$891.23$106.2B
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
MCK logo

McKesson Corporation

MCK
NYSE · Medical Distribution
$891.23
At close - Sep 22, 4:00 PM EDT - USD
Market Cap$106.23B
P/E23.2x
52W High$999.00
Volume852.47K
OverviewTerminalAnalysisFinancialsValuationEarningsBreakoutsOwnership
VCP Research Verdict2027Q1

Accelerating Growth Amid Thin Margins and Negative Equity

McKesson's revenue growth accelerated to 7.7% in 2027Q1, driven by specialty distribution and RxTS expansion, yet gross margins remain razor-thin at 3.5%. The company's asset-light model generates strong cumulative cash flow ($16.4B OCF vs. $9.5B net income ov...

GrowthAccelerating
ProfitabilityModerate
ValuationExpensive
TechnicalsHealthy
Explore valuation models
MARKET ACTION

MCK price & volume

Price trend, volume and key moving averages

Launch Terminal
Loading chart...
Decision Checklist4 Core Signals

What matters now

The signals most likely to change the investment case.

01

Earnings momentum

10/12 Beats

EPS beat 10 of last 12 quarters

02

Valuation risk

-13% Peers

P/E is 13% below peer median

03

Market leadership

RS 62 · Avg

Average momentum (RS Rating: 62)

04

Healthy Uptrend

Uptrend

Price > 50DMA > 200DMA

Next CatalystEstimated earnings · Nov 5
01

Build the investment case

Start with the evidence for owning the stock and the risks that can break the thesis.

EXECUTIVE THESIS

The Investment Case

Full Analysis
Fundamental Trajectory

Revenue growth accelerated to 7.7% in 2027Q1, but gross margin contracted to 3.5% from 4.5% in 2024Q4, reflecting a mix shift toward lower-margin distribution.

Analyst Consensus+6.9% target
Buy(31 analysts)
25 Buy6 Hold0 Sell

The Bull Case

Upside Catalysts

Wide economic moat

McKesson Corporation has a wide moat, making it a resilient player in the healthcare distribution sector, as highlighted in its moat analysis and institutional ownership.

Strong institutional backing

Top holder Vanguard Group owns 11.8% of McKesson, signaling strong institutional confidence in the company's long-term prospects.

Healthcare logistics backbone

McKesson serves as the logistical and operational backbone of the U.S. healthcare system, ensuring steady demand for its services.

The Bear Case

Key Downside Risks

Market performance

Price History →

Trailing total returns as of 9/23/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC).

YTD Return
MCK+8.55%
S&P 500 (^GSPC)+13.20%
1-Year Return
MCK+28.35%
S&P 500 (^GSPC)+15.98%
3-Year Return
MCK+105.20%
S&P 500 (^GSPC)+80.50%
5-Year Return
MCK+346.30%
S&P 500 (^GSPC)+76.14%
02

Test the fundamentals

Check whether operating performance supports the current valuation.

VALUATION & INTRINSIC VALUE

Valuation Scenarios

Valuation Analysis
Trailing P/EMedian
23.2x
Forward P/EExpansion
20.0x
EV/EBITDA40th %ile
15.4x
FCF YieldCash Flow
5.4%

Valuation vs 5-Year History

Multiple Range
Metric
Current
5Y Median
Historical Range
Percentile
P/E
23.2x
24.0x
40th· Fair
EV/EBITDA
15.4x
15.6x
40th· Fair
Price/FCF
18.6x
16.5x
60th· Fair
Current Multiple
5Y Median (50th %ile)

Intrinsic Value Scenarios

DCF Projection
No DCF Model AvailableIntrinsic value modeling is not supported for this equity.

Growth & profitability

Annual revenue & EPS trend
Revenue
$403.43B+12.4% YoY
Net income
$4.76B+44.5% YoY
Free cash flow
$5.72B+9.4% YoY
Operating margin
1.6%+0.4 pts YoY
ROIC (TTM)254.1%
Avg ROIC 5Y-
ROE (TTM)-
Piotroski Score7 / 9
Financial Statements →
03

Monitor what changed

Recent results and news deserve attention only when they alter the forward view.

OPERATING RESULTS

Recent Earnings

Earnings History
EPS Beat Rate10/12 (83%)
Revenue Beat Rate6/12 (50%)
QuarterEPS (Act vs Est)Revenue (Act vs Est)
Q3 2026Latest
Aug 5, 2026
$9.93+3.9%
vs $9.56
$105.4B+1.4%
vs $103.9B
Q2 2026
May 7, 2026
$11.69+1.1%
vs $11.56
$96.3B-5.0%
vs $101.3B
Q1 2026
Feb 4, 2026
$9.34+1.9%
vs $9.17
$106.2B+0.3%
vs $105.8B
Q4 2025
Nov 5, 2025
$9.86+9.2%
vs $9.03
$103.2B-0.9%
vs $104.1B
Historical baseline: 12 quarters analyzedGAAP / Adjusted
MARKET COVERAGE

Latest News

5 Stories
Zacks Investment Research·1d ago
Why McKesson (MCK) is a Top Growth Stock for the Long-Term

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Defense World·4d ago
Nykredit A S Buys Shares of 48,302 McKesson Corporation $MCK

Nykredit A S purchased a new position in McKesson Corporation (NYSE: MCK) during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm purchased 48,302 shares of the company's stock, valued at approximately $36,497,000. Several other hedge funds and other institutional investors have also modified

Zacks Investment Research·6d ago
McKesson (MCK) Sees a More Significant Dip Than Broader Market: Some Facts to Know

McKesson (MCK) closed at $887.29 in the latest trading session, marking a -1.36% move from the prior day.

Defense World·Sep 15, 2026
Bank of America Corp DE Acquires New Stake in McKesson Corporation $MCK

Bank of America Corp DE acquired a new stake in McKesson Corporation (NYSE: MCK) during the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm acquired 1,321,991 shares of the company's stock, valued at approximately $998,896,000. Bank of America Corp DE owned

Filtered for McKesson CorporationMore Headlines
04

Compare before deciding

Benchmark MCK against direct peers instead of judging its metrics in isolation.

Peers Comparison

Key metrics vs top competitors for McKesson Corporation (MCK)

Full Screener →
CompanyPriceMarket CapP/E RatioRev Growth (1Y)Net MarginROEDiv Yield
MCK logoMCKMcKesson CorporationCurrent
$891.23$106.23B23.2212.36%1.18%—0.34%
CAH logoCAHCardinal Health, Inc.
$222.04$52B30.71299.31%0.67%——
HSIC logoHSICHenry Schein, Inc.
$87.43$9.96B26.744.03%2.96%8.38%—
CVS logoCVSCVS Health Corp.
$87.10$111.13B62.667.85%1.18%6.41%—
CI logoCICigna Corporation
$273.74$72.41B12.3511.26%2.27%15.16%—
OMI logoOMIOwens & Minor, Inc.
$2.24$171.11M-0.16-74.19%-39.85%——

Compare MCK vs Peers

McKesson Corporation (MCK) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.

Closest Rival

vs CAH

Most directly comparable listed peer for MCK.

Scale Benchmark

vs AMZN

Larger-name benchmark to compare MCK against a more recognizable public peer.

Peer Set

Compare Top 5

vs CAH, HSIC, CVS, CI

05

Keep researching

Verify the primary filings, follow material updates, and answer the remaining questions.

MCK SEC Filings & Documents

McKesson Corporation (MCK) SEC filings — annual & quarterly reports (10-K, 10-Q)

8-K Announcements

6
Material company update

Aug 5, 2026·SEC

Material company update

Jul 24, 2026·SEC

Material company update

Jul 1, 2026·SEC

10-K Annual Reports

3
FY 2026

May 8, 2026·SEC

FY 2025

May 9, 2025·SEC

FY 2024

May 8, 2024·SEC

10-Q Quarterly Reports

6
FY 2026

Aug 5, 2026·SEC

FY 2026

Feb 4, 2026·SEC

FY 2025

Nov 6, 2025·SEC

Get notified when MCK posts new earnings or crosses analyst targets

Free. No account needed. Unsubscribe any time.

Free. Unsubscribe any time.

MCK Frequently Asked Questions

McKesson Corporation (MCK) stock FAQ — growth, dividends, profitability & financials explained

Growth & Financials
What is McKesson Corporation's revenue?

McKesson Corporation (MCK) reported $410.98B in revenue for fiscal year 2026. This represents a 3089% increase from $12.89B in 1997.

How fast is McKesson Corporation growing?

McKesson Corporation (MCK) grew revenue by 12.4% over the past year. This is steady growth.

Is MCK profitable?

Yes, McKesson Corporation (MCK) is profitable, generating $4.59B in net income for fiscal year 2026 (1.2% net margin).

Dividend & Returns
Does MCK pay dividends?

Yes, McKesson Corporation (MCK) pays a dividend with a yield of 0.34%. This makes it attractive for income-focused investors.

What is McKesson Corporation's free cash flow?

McKesson Corporation (MCK) generated $6.63B in free cash flow for fiscal year 2026. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.

What if you invested $1,000 in MCK back in 1997?

Total return calculator · dividends reinvested · 29+ years of data

See returns →